MRK vs SOLV
By Alex · Tickerpine
Merck & Co., Inc. vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | SOLV |
|---|---|---|
| Price | $147.76 | $89.08 |
| Market cap | $364.26B | $15.14B |
| P/E ratio | 149.3 | 100.1 |
| ROE | 5.06% | 3.19% |
| Profit margin | 3.64% | 1.91% |
| Revenue growth | 4.70% | -7.00% |
| Dividend yield | 2.30% | 0.00% |
| Beta | 0.12 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs SOLV in plain English
- MRK is the bigger company — about 24.1× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 100.1 vs 149.3).
- MRK earns a higher return on equity (5% vs 3%).
- MRK is growing revenue faster (5% vs -7%).
- MRK pays a dividend (2.30%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.